Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2001
Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts
D C Saffran, A B Raitano, R S Hubert, et al.
Genes, Chromosomes & Cancer
|
November 24, 1999
Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer
R E Reiter, I Sato, G Thomas, et al.
Cancer Research
|
June 19, 2001
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
N Amara, G S Palapattu, M Schrage, et al.
Prostate Cancer and Prostatic Diseases
|
February 1, 2017
Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy
J V Hegde, D J Margolis, P-C Wang, et al.
Cancer Research
|
June 15, 1993
Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors
M Makos, B D Nelkin, R E Reiter, et al.
The Journal of Urology
|
February 25, 1998
Low p27 expression predicts poor disease-free survival in patients with prostate cancer
R M Yang, J Naitoh, M Murphy, et al.
Cancer Research
|
October 16, 1999
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process
N Craft, C Chhor, C Tran, et al.
The Journal of Urology
|
November 4, 2000
Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage
G V Thomas, M I Schrage, L Rosenfelt, et al.
Oncogene
|
March 14, 2000
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
Z Gu, G Thomas, J Yamashiro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 1998
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
Y E Whang, X Wu, H Suzuki, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2001
Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts
D C Saffran, A B Raitano, R S Hubert, et al.
Genes, Chromosomes & Cancer
|
November 24, 1999
Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer
R E Reiter, I Sato, G Thomas, et al.
Cancer Research
|
June 19, 2001
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma
N Amara, G S Palapattu, M Schrage, et al.
Prostate Cancer and Prostatic Diseases
|
February 1, 2017
Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy
J V Hegde, D J Margolis, P-C Wang, et al.
Cancer Research
|
June 15, 1993
Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors
M Makos, B D Nelkin, R E Reiter, et al.
The Journal of Urology
|
February 25, 1998
Low p27 expression predicts poor disease-free survival in patients with prostate cancer
R M Yang, J Naitoh, M Murphy, et al.
Cancer Research
|
October 16, 1999
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process
N Craft, C Chhor, C Tran, et al.
The Journal of Urology
|
November 4, 2000
Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage
G V Thomas, M I Schrage, L Rosenfelt, et al.
Oncogene
|
March 14, 2000
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
Z Gu, G Thomas, J Yamashiro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 1998
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
Y E Whang, X Wu, H Suzuki, et al.
Page
of 3